BALCX | CLREX | BALCX / CLREX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 14 years | - |
Gain YTD | 1.938 | 1.209 | 160% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 240B | 9.75B | 2,463% |
Annual Yield % from dividends | 1.59 | 1.96 | 81% |
Returns for 1 year | 11.44 | 10.38 | 110% |
Returns for 3 years | 10.59 | 10.09 | 105% |
Returns for 5 years | 25.92 | 24.13 | 107% |
Returns for 10 years | 49.96 | 60.24 | 83% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FNGS | 57.97 | 0.96 | +1.68% |
MicroSectors™ FANG+™ ETN | |||
HDUS | 57.68 | 0.54 | +0.95% |
Hartford Disciplined US Equity ETF | |||
GHTA | 28.54 | 0.10 | +0.37% |
Goose Hollow Tactical Allocation ETF | |||
DES | 34.73 | 0.07 | +0.20% |
WisdomTree US SmallCap Dividend ETF | |||
BIS | 18.25 | N/A | N/A |
ProShares UltraShort Nasdaq Biotech |